Search Results (77)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Sand, Peter | Person |
Why?
|
| Sacral Neuromodulation is Preferred over OnabotulinumtoxinA Injection for Overactive Bladder in Women: Con. | Academic Article |
Why?
|
| Botulinum toxin A in the overactive bladder: current status and future directions. | Academic Article |
Why?
|
| Does physician specialty affect persistence to pharmacotherapy among patients with overactive bladder syndrome? | Academic Article |
Why?
|
| Efficacy and safety of oxybutynin chloride topical gel for women with overactive bladder syndrome. | Academic Article |
Why?
|
| Efficacy and tolerability of fesoterodine in women with overactive bladder. | Academic Article |
Why?
|
| Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome. | Academic Article |
Why?
|
| Extended-release trospium chloride improves quality of life in overactive bladder. | Academic Article |
Why?
|
| Intravesical botulinum type A toxin injection in patients with overactive bladder: Trigone versus trigone-sparing injection. | Academic Article |
Why?
|
| Is There a Relationship Between Patient-Reported Satisfaction and Persistence on Overactive Bladder Syndrome Pharmacotherapy? | Academic Article |
Why?
|
| Overactive bladder and outlet obstruction in men. | Academic Article |
Why?
|
| Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndrome. | Academic Article |
Why?
|
| Role of botulinum toxin-A in refractory idiopathic overactive bladder patients without detrusor overactivity. | Academic Article |
Why?
|
| Subjective measures of efficacy and quality of life in overactive bladder syndrome. | Academic Article |
Why?
|
| The evolution of transdermal therapy for overactive bladder. | Academic Article |
Why?
|